Buy Lantern Pharma Stock | LTRN Stock Price & Latest News | Public
LTRN

Lantern Pharma

$0.00 (0.00%)Today

    About LTRN

    Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.12
    -0.24
    -0.36
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.36

    Actual EPS
    Q3 2020

    Stats

    Market Cap$99,54M
    Volume105
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$19.50
    1 Year Low$10.40
    Open$16.21
    High$16.80
    Low$16.21

    Buy any stock with any amount of money.

    Download the App
    Download the app